Research Article

A Nomogram Model Based on Noninvasive Bioindicators to Predict 3-Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study

Table 3

Results of univariate and multivariate analysis for NAFLD risk prediction.

VariablesUnivariate analysisMultivariate analysis
HR (95% CI) valueHR (95% CI) value

Gender
 FemaleReference
 Male1.04 (0.92, 1.16)NS
Age1.00 (1.00, 1.01)0.0120.99 (0.98, 1.01)NS
ALP1.01 (1.01, 1.01)<0.0011.00 (1.00, 1.00)NS
AST1.01 (1.00, 1.01)<0.0010.99 (0.97, 1.02)NS
TP1.02 (1.01, 1.03)0.0011.01 (0.99, 1.02)NS
ALB1.04 (1.02, 1.06)<0.0010.99 (0.97, 1.02)NS
GLB1.01 (0.99, 1.02)NS
BUN0.89 (0.85, 0.93)<0.0010.90 (0.78, 1.02)NS
Cr1.00 (1.00, 1.00)0.0011.00 (1.00, 1.00)NS
UA1.00 (1.00, 1.00)<0.0011.00 (1.00, 1.00)NS
FPG1.23 (1.18, 1.28)<0.0011.17 (1.11, 1.22)<0.001
TC1.29 (1.20, 1.39)<0.0010.80 (0.57, 1.03)NS
HDL-c0.29 (0.25, 0.35)<0.0010.72 (0.55, 0.92)0.010
LDL-c1.69 (1.49, 1.91)<0.0011.63 (1.31, 2.02)<0.001
BMI1.64 (1.58, 1.71)<0.0011.43 (1.37, 1.49)<0.001
SBP1.01 (1.01, 1.01)<0.0010.99 (0.99, 1.00)NS
DBP1.03 (1.03, 1.04)<0.0011.00 (0.99, 1.01)NS
Lg (GGT)6.21 (5.25, 7.34)<0.0011.96 (1.51, 2.53)<0.001
Lg (ALT)7.82 (6.45, 9.47)<0.0015.23 (3.52, 7.78)<0.001
Lg (TB)0.60 (0.43, 0.85)0.0049.35 (5.86, 14.93)<0.001
Lg (DBIL)0.10 (0.08, 0.12)<0.0010.06 (0.05, 0.08)<0.001
Lg (TG)18.26 (14.65, 22.75)<0.0012.62 (1.74, 3.93)<0.001

NAFLD: nonalcoholic fatty liver disease; ALP: alkaline phosphatase; GGT: γ-glutamyl transpeptidase; ALT: alanine aminotransferase; AST: aspartate aminotransferase; TP: total protein; ALB: albumin; GLB: globulin; TB: total bilirubin; DBIL: direct bilirubin; BUN: blood urea nitrogen; Cr: creatinine; UA: uric acid; FPG: fasting plasma glucose; TC: total cholesterol; TG: triglyceride; HDL-c: high-density lipoprotein cholesterol; LDL-c: low-density lipoprotein cholesterol; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: hazard ratio; CI: confidence interval; NS: no significance.